Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody Meeting Abstract

  

Authors:	Schindler, K.; Harmankaya, K.; Postow, M. A.; Frantal, S.; Bello, D.; Ariyan, C. E.; Michielin, O. A.; Hoeller, C.; Pehamberger, H.; Wolchok, J. D.
Abstract Title:	Pretreatment levels of absolute and relative eosinophil count to improve overall survival (OS) in patients with metastatic melanoma under treatment with ipilimumab, an anti CTLA-4 antibody
Meeting Title:	49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	31
Issue:	15 Suppl.
Meeting Dates:	2013 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2013-05-20
Language:	English
ACCESSION:	WOS:000335419602725
PROVIDER:	wos
DOI:	10.1200/jco.2013.31.15_suppl.9024
Notes:	Meeting Abstract: 9024 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/128789